Target intelligence / Profile preview

Lipopolysaccharide transport protein B2FGC complex (LptB2FGC) (LptB2FGC)

Target
LptB2FGC
Molecular classification
ABC transporter, Transporter, Protein complex
01

Overview

The Lipopolysaccharide transport protein B2FGC complex (LptB2FGC) is an essential ATP-binding cassette (ABC) transporter located in the inner membrane of Gram-negative bacteria [1, 2]. It is responsible for the extraction of mature lipopolysaccharide (LPS) molecules from the inner membrane and their subsequent translocation across the periplasm to the outer membrane [2, 5]. The complex consists of two LptB ATPase subunits, the transmembrane proteins LptF and LptG, and the regulatory protein LptC [1, 4]. This machinery is critical for maintaining the integrity and impermeability of the bacterial outer membrane, which serves as a primary defense against environmental stressors and antibiotics [1, 6]. Because of its essential role in bacterial viability and its absence in eukaryotic cells, the LptB2FGC complex is a high-priority target for the development of novel antibiotics [5, 6]. Drugs like Zosurabalpin work by trapping LPS within the transporter's cavity, leading to toxic accumulation of LPS in the inner membrane and bacterial cell death [6]. Recent research has also identified that the complex possesses adenylate kinase activity, which may play a role in regulating its transport function [3, 7]. Inhibition of this complex not only kills the bacteria but also sensitizes them to other antibiotics by compromising the outer membrane barrier [12].

Other names
LptB2FG-C complexInner membrane lipopolysaccharide transporterLptB2FG complexLPS transport machinery
02

Mechanism of action

Inhibition of lipopolysaccharide extraction from the inner membrane by trapping the substrate within the transporter cavity and uncoupling ATP hydrolysis from transport [6].

03

Biological functions

Lipopolysaccharide transportOuter membrane biogenesisATP hydrolysisAdenylate kinase activity
04

Disease associations

Infection
05

Safety considerations

Development of antibiotic resistance through target mutationsNarrow spectrum of activity for specific inhibitors
06

Interacting drugs

Zosurabalpin

3 more in the full profile.

07

Biomarkers

LPS accumulation in the inner membranelptF mutationslptG mutations

Beyond the preview

Go deeper on Lipopolysaccharide transport protein B2FGC complex (LptB2FGC) (LptB2FGC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipopolysaccharide transport protein B2FGC complex (LptB2FGC) (LptB2FGC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call